low dose CBD

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

Medical

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

March 26, 2026

Avecho CEO predicts takeover, soaring valuation if CBD sleep capsule clears phase III trial

Medical

Avecho CEO predicts takeover, soaring valuation if CBD sleep capsule clears phase III trial

March 11, 2025

Sandoz commits A$4.8 million to Avecho in push for over-the-counter CBD sleep treatment

Finance

Sandoz commits A$4.8 million to Avecho in push for over-the-counter CBD sleep treatment

March 03, 2025

Gibraltar-Based Firm Acquires Bod Science's Low-Dose CBD Trial Data and IP Assets

Finance

Gibraltar-Based Firm Acquires Bod Science's Low-Dose CBD Trial Data and IP Assets

January 30, 2025

Ecofibre Plans Second Clinical Trial to Support S3 CBD Product Push

Medical

Ecofibre Plans Second Clinical Trial to Support S3 CBD Product Push

February 01, 2023

New Zealand Committee Rejects Over-the-Counter CBD Proposal, Frustrating Industry

Medical

New Zealand Committee Rejects Over-the-Counter CBD Proposal, Frustrating Industry

December 05, 2022